Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Galapagos has announced that its service division BioFocus DPI will provide compound management and related services to Sepracor. Total contract value for Galapagos is E1 million.
Subscribe to our email newsletter
Under the terms of the agreement, BioFocus DPI will receive, register, and store selected compounds from Sepracor’s proprietary compound library, and plate and replicate these compounds for a period of three years. Services will be provided by BioFocus DPI’s compound management facility in South San Francisco, US.
Onno van de Stolpe, CEO of Galapagos, said: “Our compound management site has been able to broaden its customer base over the last year, and with this agreement we further expand our list of pharma companies.”